Safdarjung Hospital Neurosurgeon Among 5 Arrested By CBI

New Delhi : The Central Bureau of Investigation (CBI) on Thursday (March 30) arrested a neurosurgeon from Delhi’s Safdarjung Hospital and four accomplices who allegedly forced patients to buy surgical equipment from a specific establishment at exorbitant prices.

The agency raided several Delhi and Uttar Pradesh locations linked to Manish Rawat, the neurosurgeon, and busted the nefarious nexus, news agency PTI reported citing officials.

Following an extensive investigation, the CBI apprehended Rawat and four of his associates, including Deepak Khattar, the proprietor of Kanishka Surgical in New Delhi, and middlemen Avnesh Patel, Manish Sharma, and Kuldeep, according to a CBI spokesperson.

Bribery and corruption were the charges levelled against them.

The CBI has charged Rawat with conspiring with others to extract payment from patients for medical consultations and surgical procedures while violating the hospital’s established protocols.

The agency also claims that the surgeon directed his patients to buy surgical instruments from Khattar’s shop, forcing them to pay inflated prices.

According to the spokesperson, the doctor coerced patients into paying more than the actual price for the surgical items, and the shop owner split the profits from overbilling with the accused physician.

The investigation also revealed that Rawat directed his patients to deposit bribes ranging from Rs 30,000 to Rs 1.15 lakh into a middleman’s bank account, the officials said.

Rawat has also been accused of syphoning off the excess money generated by the sale of overpriced surgical equipment, enriching himself and his co-conspirators through bribes, and laundering their ill-gotten gains through various companies controlled by a private individual.

  • Related Posts

    Gene Therapy for Cholesterol: Initial Test Results Cheer

    Eli Lilly working on single-dose drug to be administered via IV for long-term gain Mumbai: For millions of heart patients struggling with elevated levels of cholesterol, there is a ray…

    US Biotech Regeneron to launch Global Capability Centre in Hyderabad

    Regeneron Pharmaceuticals, Inc. has announced plans to establish the Regeneron Global Capability Centre (GCC) in Hyderabad, a strategic investment that deepens its global operations and scales business functions to advance…

    Leave a Reply

    Your email address will not be published. Required fields are marked *

    You Missed

    Gene Therapy for Cholesterol: Initial Test Results Cheer

    Gene Therapy for Cholesterol: Initial Test Results Cheer

    US Biotech Regeneron to launch Global Capability Centre in Hyderabad

    US Biotech Regeneron to launch Global Capability Centre in Hyderabad

    Popped the Pill, Paid the Price to Potentially Fatal Skin Syndrome

    Popped the Pill, Paid the Price to Potentially Fatal Skin Syndrome

    Former Advisor to India’s Union Health Ministry gets Quite a Feather in his Cap

    Former Advisor to India’s Union Health Ministry gets Quite a Feather in his Cap

    Alembic Pharma Secures USFDA Approval for Generic Synthroid Tablets

    Alembic Pharma Secures USFDA Approval for Generic Synthroid Tablets

    STF busts fake meds racket spread across 6 states

    STF busts fake meds racket spread across 6 states